Growth factors and their impact on transfusion medicine

Vox Sanguinis
Y M Miller, H G Klein

Abstract

Hematopoietic growth factors, glycoproteins that stimulate self-renewal, differentiation, and proliferation of responsive hematopoietic cells, promise to revolutionize transfusion medicine. Recombinant DNA technology has made several of these cytokines available at pharmacologic doses, and new candidate agents for clinical application appear regularly. Growth factors prescribed for patients have already reduced the requirement for red blood cell and granulocyte transfusions in selected clinical circumstances. A lineage-specific thrombopoietin will likely limit the need for platelet transfusions. Hematopoietic cytokine injections have also been used to increase the number of red blood cells, granulocytes and circulating primitive progenitor cells in blood donors. Cytokine-stimulated peripheral blood progenitor cell infusions have complemented and, in some instances, replaced bone marrow for adjunctive cancer chemotherapy and for bone marrow transplantation. Finally, synergistic combinations of cytokines can effect ex vivo expansion of lymphocytes and of progenitor cells to provide novel blood components. Hematopoietic growth factors are still expensive and their long-term effects remain to be determined. However, as the biologic...Continue Reading

References

Mar 1, 1992·Journal of Cardiovascular Pharmacology·J van WijngaardenH Wesseling
May 9, 1991·The New England Journal of Medicine·A J Erslev
May 1, 1991·The Annals of Thoracic Surgery·V A Gaudiani, H D Mason
Jun 14, 1990·The New England Journal of Medicine·C B MillerJ L Spivak
Nov 1, 1993·Transfusion·L T GoodnoughL E Silberstein
Apr 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M Vose, J O Armitage
Jan 14, 1993·The New England Journal of Medicine·G P RodgersA W Nienhuis
Jan 1, 1994·Stem Cells·A Gianella-Borradori
Dec 1, 1994·Archives of Disease in Childhood·I M Hann
May 1, 1995·Transfusion·J McCullough
Jan 1, 1994·Stem Cells·D R ParkinsonM C Christian
May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S CascinuG Catalano
May 1, 1994·Plastic and Reconstructive Surgery·J W PolleyD W Penney
Mar 1, 1994·Oncology·J S Cebon, G J Lieschke

❮ Previous
Next ❯

Citations

Jul 22, 1998·Transfusion Medicine Reviews·G Ramsey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.